Clinical Trial Update: Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA [Phase 2]

View source ↗

Summary

Phase 2 trial of neoadjuvant chemohormonal therapy followed by salvage surgery for high-risk prostate cancer; study terminated with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-08-05